These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8099970)
41. Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder. Manor I; Newcorn JH; Faraone SV; Adler LA Postgrad Med; 2013 Jul; 125(4):181-90. PubMed ID: 23933905 [TBL] [Abstract][Full Text] [Related]
42. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain. Riegert C; Wedekind F; Hamida SB; Rutz S; Rothmaier AK; Jones BC; Cassel JC; Jackisch R Int J Neuropsychopharmacol; 2008 Sep; 11(6):743-63. PubMed ID: 18248690 [TBL] [Abstract][Full Text] [Related]
43. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum]. Sheng JG Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971 [TBL] [Abstract][Full Text] [Related]
44. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum. Camarero J; Sanchez V; O'Shea E; Green AR; Colado MI J Neurochem; 2002 Jun; 81(5):961-72. PubMed ID: 12065608 [TBL] [Abstract][Full Text] [Related]
45. Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice. Zhang Y; Picetti R; Butelman ER; Schlussman SD; Ho A; Kreek MJ Neuropsychopharmacology; 2009 Mar; 34(4):912-22. PubMed ID: 18784649 [TBL] [Abstract][Full Text] [Related]
46. Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice. Miville-Godbout E; Bourque M; Morissette M; Al-Sweidi S; Smith T; Jayasinghe D; Ritchie S; Di Paolo T Brain Res; 2017 Nov; 1674():70-76. PubMed ID: 28830769 [TBL] [Abstract][Full Text] [Related]
47. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats. Batool F; Hasnat A; Haleem MA; Haleem DJ Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850 [TBL] [Abstract][Full Text] [Related]
48. Effects of baclofen and gamma-hydroxybutyrate on rat striatal and mesolimbic 5-HT metabolism. Waldmeier PC; Fehr B Eur J Pharmacol; 1978 May; 49(2):177-84. PubMed ID: 658133 [TBL] [Abstract][Full Text] [Related]
49. Increased striatal dopamine turnover following acute administration of rotenone to mice. Thiffault C; Langston JW; Di Monte DA Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582 [TBL] [Abstract][Full Text] [Related]
50. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons. Rothblat DS; Schneider JS Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679 [TBL] [Abstract][Full Text] [Related]
52. [Metadoxine in alcohol-related pathology]. Santoni S; Corradini P; Zocchi M; Camarri F Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084 [TBL] [Abstract][Full Text] [Related]
53. Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment. Anitha M; Abraham PM; Paulose CS Eur J Pharmacol; 2012 Dec; 696(1-3):54-61. PubMed ID: 23001013 [TBL] [Abstract][Full Text] [Related]
54. Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice. Miville-Godbout E; Bourque M; Morissette M; Al-Sweidi S; Smith T; Mochizuki A; Senanayake V; Jayasinghe D; Wang L; Goodenowe D; Di Paolo T PLoS One; 2016; 11(3):e0151020. PubMed ID: 26959819 [TBL] [Abstract][Full Text] [Related]
55. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry. Hefti F; Melamed E Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794 [TBL] [Abstract][Full Text] [Related]
56. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Broening HW; Morford LL; Vorhees CV Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503 [TBL] [Abstract][Full Text] [Related]
57. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder. Manor I; Ben-Hayun R; Aharon-Peretz J; Salomy D; Weizman A; Daniely Y; Megiddo D; Newcorn JH; Biederman J; Adler LA J Clin Psychiatry; 2012 Dec; 73(12):1517-23. PubMed ID: 23290324 [TBL] [Abstract][Full Text] [Related]